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Abstract
Ghrelin-system components [native ghrelin, In1-ghrelin, Ghrelin-O-acyltransferase enzyme (GOAT) and receptors (GHS-Rs)]
are expressed in a wide variety of tissues, including the pancreas, where they exert different biological actions including
regulation of neuroendocrine secretions, food intake and pancreatic function. The expression of ghrelin system is regulated
by metabolic conditions (fasting/obesity) and is associated with the progression of obesity and insulin resistance. Cortistatin
(CORT), a neuropeptide able to activate GHS-R, has emerged as an additional link in gut-brain interplay. Indeed, we recently
reported that male CORT deficient mice (cort2/2) are insulin-resistant and present a clear dysregulation in the stomach
ghrelin-system. The present work was focused at analyzing the expression pattern of ghrelin-system components at
pancreas level in cort2/2 mice and their control littermates (cort +/+) under low- or high-fat diet. Our data reveal that all
the ghrelin-system components are expressed at the mouse pancreatic level, where, interestingly, In1-ghrelin was expressed
at higher levels than native-ghrelin. Thus, GOAT mRNA levels were significantly lower in cort2/2 mice compared with
controls while native ghrelin, In1-ghrelin and GHS-R transcript levels remained unaltered under normal metabolic
conditions. Moreover, under obese condition, a significant increase in pancreatic expression of native-ghrelin, In1-ghrelin
and GHS-R was observed in obese cort+/+ but not in cort2/2 mice. Interestingly, insulin expression and release was
elevated in obese cort+/+, while these changes were not observed in obese cort2/2 mice. Altogether, our results indicate
that the ghrelin-system expression is clearly regulated in the pancreas of cort+/+ and cort2/2 under normal and/or obesity
conditions suggesting that this system may play relevant roles in the endocrine pancreas. Most importantly, our data
demonstrate, for the first time, that endogenous CORT is essential for the obesity-induced changes in insulin expression/
secretion observed in mice, suggesting that CORT is a key regulatory component of the pancreatic function.
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Introduction
Ghrelin gene (GHRL) is a complex gene whose processing
generates, either through alternative splicing or post-translational
modifications, a wide variety of transcripts and proteins with
multiple functions [1,2,3,4]. The main transcript of GHRL (pre-
pro-ghrelin) encodes the well-known native-ghrelin (henceforth
referred to as ghrelin) and obestatin (23aa). Ghrelin is a 28-amino
acid multifunctional hormone predominantly produced by the
stomach, but also lower amounts are generated in wide variety of
tissues including the pancreas, where it can act as a paracrine/
autocrine factor [5,6,7,8,9]. Ghrelin displays the unique distinctive
feature to be acylated at its third residue (Ser) by the addition of
a middle-chain fatty acid (n-octanoic acid) catalyzed by the
enzyme ghrelin O-acyltransferase (GOAT). Afterward, either
acylated or unacylated-proghrelin can be further processed by
the prohormone convertase 1/3 (PC1/3) thus generating the
acylated-ghrelin or its unacylated-ghrelin counterpart, a form of
ghrelin initially considered as inactive ([2]). Ghrelin acylation is
crucial for its biological activity, and endows ghrelin as the natural
ligand of the ghrelin receptor [formerly known as growth hormone
(GH) secretagogue receptor (GHSR)] [10,11,12]. In addition to
pre-pro-ghrelin, other splice variants of GHRL, such as In1-
ghrelin or des-Glu14-Ghrelin can also be generated in several
tissues ([13]; [2]). Particularly, the In1-ghrelin variant, which
retains the GHRL intron-1 sequence [13,14], are regulated in
a tissue-dependent manner by metabolic status and display patho-
physiological relevance at different levels [13,14]. Importantly,
In1-ghrelin variant is also susceptible to be acylated since it shares
the same start codon, the signal peptide and the first 12aa of
ghrelin, which includes the putative acylation site at Ser3 and the
residues found to be necessary for acylation (Gly1 and Phe4) [14].
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Although it has been documented that ghrelin-derived pep-
tides/GOAT/GHSR comprise an important regulatory system for
the modulation of pancreatic function, questions remain unan-
swered regarding the mechanism(s) by which the ghrelin-system is
locally produced and regulated under normal and obese condi-
tions. In line with this, our group and others have suggested the
existence of a unique functional interaction between the ghrelin-
system and cortistatin (CORT), a peptide that shares high
structural and functional similarities with somatostatin (SST).
Specifically, it has been reported that CORT, but not SST, binds
with high affinity to the GHSR, and that some endocrine actions
of CORT are mediated through the GHSR [15,16]. Moreover,
we have recently reported that endogenous CORT is substantially
involved in the control of insulin/glucose homeostasis, which was
associated with drastic changes in circulating ghrelin [16]. Based
on these observations, the study of the plausible involvement of
CORT in the regulation of the different components of the
ghrelin-system could shed new light in the complex relationship
between these regulatory systems (CORT/ghrelin) in pancreatic
function under normal and pathological states. To this end, in the
present work we sought to investigate, for the first time, the
expression and regulation of the ghrelin–system (native-ghrelin,
In1-ghrelin, GHSR and GOAT) as well as of insulin levels in the
pancreas of cort+/+ and cort2/2 mice under basal and obese
conditions.
Materials and Methods
Ethics Statement
All experimental procedures for animal care and experimenta-
tion were approved by the Ethical Committee of the Cordoba
University.
Animals
CORT knockout mice (cort 2/2) and their respective
littermate controls (cort +/+) were generated from an in-house
breeding colony [16]. Genotypes were determined by convention-
al PCR from snipped tails as previously described [16]. All animals
were housed under standard conditions of light cycle (12 h light:
12 h dark) and temperature (22–24uC), with standard food (SAFE-
diets; Barcelona, Spain) and water ad libitum until the experimental
diet-induced obesity was performed (see below). In order to reduce
the stress, animals were handled every day for 2 weeks (wk) before
the sacrifice.
Experimental Design and Diet-induced Obesity (DIO)
At 4 wk of age, male mice were single-housed and fed for 16 wk
a low-fat diet (LFD: 10 kcal% from fat, 70 kcal% from carbohy-
drates and 20 kcal% from proteins) or under a high-fat diet (HFD:
60 kcal% from fat, 20 kcal% from carbohydrates, 20 kcal% from
proteins) (Research Diets, Gentofte, Denmark) [17].
Samples
At the end of the experiment, animals were sacrificed, all efforts
were made to minimize suffering, and the pancreas immediately
removed and processed for either islet isolation (see below) or
RNA isolation. For RNA isolation, whole pancreas was immersed
in Trizol reagent, homogenized by a basic ultra-turrax (IKA,
Staufen, Germany), snap-frozen in liquid nitrogen and sub-
sequently stored at 280uC until their analysis as described below.
Islet Isolation and Culture
For islet isolation, whole pancreas was placed in ice-cold
collagenase V solution (1 mg/ml) and minced into small pieces.
Then, tissue was maintained in a collagenase solution at 37uC for
30–45 min period in a water-bath, and every 10 min pancreatic
pieces were mixed by smooth pipetting. After that, pancreatic
pieces were treated with DNAse for 10 min at 37uC and washed 3
times with Hanks solution by 800 rpm centrifugation at 4uC for
30 s. Finally, islets were poured onto a 70 mm cell strainer in order
to purify them and cultured in complete RPMI 1640 medium as
elsewhere described [18]. Finally, total RNA was isolated from
cultured islets.
RNA Isolation and Reverse Transcription (RT)
Total RNA was isolated according to Trizol reagent manu-
facturers instructions (Invitrogen, Barcelona, Spain) and treated
with DNAse kit (Promega, Madrid, Spain). For RNA isolation
from pancreatic islets, Absolutely RNA RT-PCR Miniprep Kit
with Deosyribonuclease treatment (Stratagene, La Jolla (CA),
USA) was used by following manufacturers instructions. In both
cases, total RNA was quantified by nanodrop and afterward 2 ug
of total RNA was reverse transcribed by the RevertAid First
Strand cDNA Synthesis Kit (Fermentas, Hanover, USA).
Quantitative Real-time PCR
PCR conditions, primer design and validation, as well as PCR
transcript quantification was performed as previously described
[16,17,19]. mRNA levels from whole pancreas were normalized
by a normalization factor obtained from the quantification of 3
different housekeeping genes [Cyclophilin-A, b-actin and glycer-
aldehyde-3-phosphate-dehydrogenase (GAPDH)] and generated
by the GeNorm 3.3 software [20]. Due to the limited amount of
pancreatic islet sample obtained, transcript normalization was
performed by adjusting copy number of each transcript by the
copy number of b-actin.
Assessment of Plasma Insulin
Trunk blood was collected from cort +/+ and 2/2 mice,
immediately mixed with MiniProtease inhibitor (Roche; Barce-
lona, Spain), placed on ice, centrifuged and plasma was stored at
280C until insulin determination. Circulating insulin level was
assessed by using a commercial ELISA kit (Millipore; Madrid,
Spain).
Statistical Analysis
Samples from all groups within an experiment were processed
at the same time. All data are expressed as mean 6 SEM and
obtained from a minimum of 3 and a maximum of 7 animals.
Statistical differences were determined by using Graph Pad Prism
(v.5.0.) software (GraphPad Software, Inc., La Jolla (CA) USA).
The effect of obesity and/or CORT deficiency on transcript
expression profile and circulating insulin levels in cort+/+ and cort
2/2 mice was assessed by the Student’s t-test and by ANOVA,
followed by Fishers post-hoc test for multiple comparisons. P,0,05
was considered significant.
Results
Ghrelin System Expression in Whole Pancreas and Islets
from Lean and Obese Cort+/+ and Cort 2/2 Mice
Expression of ghrelin, In1-ghrelin variant, GHS-R and GOAT
in the pancreas of cort+/+ and cort2/2mice were determined by
qRT-PCR (Fig. 1). All components of the ghrelin system were
expressed in pancreatic extracts of cort+/+ and cort2/2 mice;
however, their relative expression levels markedly differed. In-
terestingly, In1-ghrelin expression was substantially higher than
CORT Effect on Pancreatic Endocrine Function
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that of ghrelin in cort+/+ mice (834.5692.48 vs. 14.461.21
mRNA copies/NF per 100 ng total RNA, respectively; n = 5) as
well as in cort2/2 mice (1047.66105.42 vs. 16.062.09 mRNA
copies/NF per 100 ng total RNA, respectively; n = 4) (Fig. 1).
Moreover, GOAT was highly expressed as compared to ghrelin
(62.269.98 mRNA copies/NF per 100 ng total RNA), and GHS-
R showed low expression levels in cort +/+ mice under LFD
(21.163.65 mRNA copies/NF per 100 ng total RNA) (Fig. 1).
Lack of CORT, did not alter the expression of neither ghrelin
forms nor GHS-R but significantly decreased GOAT expression
(32.363.53 mRNA copies/NF per 100 ng total RNA) (Fig. 1).
Administration of HFD to prepuberal animals (4 wk of age)
during a 16 wk period caused a dysregulation of some of the
components of the ghrelin system in both whole pancreas and islet-
enriched fraction of cort+/+ animals (black columns in Fig. 1 and
2). In particular, ghrelin, In1-ghrelin and GHS-R transcript levels
were significantly higher in the whole pancreas of cort+/+ animals
fed a HFD, while GOAT mRNA levels remained unchanged
(Fig. 1). Similarly, ghrelin and GHS-R transcript expression was
increased in islet-enriched fraction under HFD conditions, while
In1-ghrelin and GOAT were not altered (black columns in Fig. 2).
Absence of CORT not only prevented the obesity-induced
increase in ghrelin, In1-ghrelin and GHS-R transcripts but also
caused a significant reduction in the expression of these transcripts
(black columns in Fig. 1). Indeed, all ghrelin-system components
were significantly decreased in obese cort2/2 compared with
obese cort+/+ mice (Figure 1). When comparing the changes in
the ghrelin-system at the pancreatic islet level with those observed
at the whole pancreas, we observed a similar, albeit not identical,
dysregulation of ghrelin system expression (Fig. 2). Specifically,
ghrelin, and GHS-R transcript levels were also significantly higher
in obese vs. lean cort+/+ mice, changes that were not observed in
obese cort2/2 mice. However, In1-ghrelin transcripts remained
unchanged in the islet-enriched fraction of cort2/2 obese mice,
while its mRNA level significantly increased as a consequence of
a HFD in cort 2/2 mice (Fig. 2).
Modulation of Plasma Insulin Levels as Well as Insulin
Expression in the Whole and Endocrine Pancreas Level in
Obese Cort+/+ and Cort2/2 Mice
Expression of insulin as well as plasma insulin levels were
analyzed in cort+/+ and cort2/2 mice under LFD and HFD
conditions. As expected, insulin expression was significantly
elevated in the whole pancreas (black columns in Fig. 3 A and
B) of HFD-fed compared to LFD- fed cort+/+ mice; while at
pancreatic islet level, only insulin-2 expression was significantly
elevated (white columns in Fig. 4). Plasma insulin levels were also
significantly elevated in cort +/+ mice under obesity conditions
(white columns in Fig. 3C). Importantly, the increased levels of
both transcript and plasma insulin as a consequence of an obese
state were completely prevented in the absence of endogenous
CORT (black columns in Fig. 3A, 3B and 4).
Figure 1. Expression level of different ghrelin system components in the whole pancreas of cort+/+ and cort2/2male mice fed a low
fat (LF) or high fat diet (HFD). Values represent mean6 SEM of copy number adjusted by normalization factor (NF) per 100 ng of cDNA obtained
from 3–7 animals per experimental group. (*: p,0,05; **: p,0,01; ***: p,0,001).
doi:10.1371/journal.pone.0057834.g001
CORT Effect on Pancreatic Endocrine Function
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Evaluation of in vitro CORT Action o Insulin Release
In order to evaluate the role of CORT on glucose-dependent
insulin secretion effect,pancreatic islets from cort2/2 mice were
cultured and treated with 10–8 M CORT, 25 mM glucose or its
joint administration, and then the insulin release was evaluated
after 24 h treatment (Fig. 5). Our data reveal that single
administration of CORT do not modify basal insulin release
while combined administration of CORT and glucose enhances
the stimulatory effect of glucose on insulin release (Fig. 5).
Discussion
This study demonstrates that endogenous cortistatin markedly
influences the expression pattern of various components of the
pancreatic ghrelin system under both normal and obesity
conditions. In addition, our data support the idea that cortistatin
play important actions on pancreatic function, as the lack of
cortistatin prevents the observed increase in the expression of
insulin and its circulating plasma levels in obese mice.
Recently, several studies have described that the pancreas
synthesizes all different components of ghrelin system, as reported
in the beta, epsilon or another endocrine cells
[5,6,8,9,10,12,21,22,23,24,25]. Accordingly, besides the well-
documented regulation of pancreatic function by ghrelin from
stomach origin [26,27,28,29], it has been also proposed that
locally produced ghrelin may have a role on pancreatic function
and, specifically, on glucose homeostasis. Indeed, Dezaki et al.
suggested that locally produced ghrelin regulates insulin pro-
duction in a paracrine manner [30], although this aspect is still
controversial [4] and consequently, a definitive role has not been
defined yet. In the present study, we confirmed pancreatic
expression of ghrelin system components (ghrelin, In1-ghrelin,
GHS-R and GOAT) in the whole pancreas and islet-enriched
cultures of control and cort2/2 mice. In addition, a significant
down-regulation of GOAT transcripts was observed in cort2/2
mice, suggesting a possible regulation of ghrelin actions by
cortistatin at pancreatic level. Similarly to that reported at the
pituitary and hypothalamus [13], we also observed that pancreatic
In1-ghrelin expression was significantly higher than that of native
ghrelin, thus supporting the idea that this variant might be the
predominant ghrelin gene derived-transcript at the pancreatic
level, and also suggesting that it may exert important biological
actions through a receptor still to be identified. Of note, In1-
ghrelin variant retains the acylation site of pre-proghrelin [10]
and, consequently, it may encode a peptide susceptible for
acylation by GOAT action. Based on the observed down-
regulation of GOAT expression in cort2/2 mice, CORT might
also regulate the putative pancreatic function of In1-ghrelin by
regulating its acylation and consequently diminishing its local
activity, an aspect that needs further attention.
Figure 2. Expression level of different ghrelin system components in pancreatic islets of cort+/+ and cort2/2 male mice fed a low
fat (LF) or high fat diet (HFD). Values represent mean6 SEM of copy number adjusted by normalization factor (NF) per 100 ng of cDNA obtained
from 4–7 animals per experimental group. (*:p,0,05; **: p,0,01; ***: p,0,001).
doi:10.1371/journal.pone.0057834.g002
CORT Effect on Pancreatic Endocrine Function
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It has been previously reported that ghrelin system components
are regulated by certain metabolic conditions, like obesity, in the
stomach, pituitary and hypothalamus [17,19,31]. In line with this,
the present report is the first to reveal, to the best of our
knowledge, that ghrelin system components are also markedly
altered under DIO conditions at pancreatic level. However,
contrary to that previously reported at the hypothalamic and
pituitary level [17,19], we observed an up-regulation of ghrelin,
In1-ghrelin and GHS-R transcripts at the pancreas of cort+/+
(control) animals under obesity conditions, while GOAT expres-
sion level remains unaltered, thus supporting that obesity-induced
alterations in the ghrelin-system are tissue-dependent. It is well
known that obesity is a chronic inflammation condition that causes
a deleterious effect on pancreatic function and, in particular, on
beta-cell function [32]. In this sense, the observed increase in
pancreatic ghrelin system expression may locally acts as a pro-
tective mechanism by promoting beta-cell survival and growth,
a function that has been previously described for different ghrelin
Figure 3. Expression profile of insulin 1 and insulin 2 (panels A
and B, respectively) in the whole pancreas of cort+/+ and
cort2/2 male mice fed a low fat (LF) or high fat diet (HFD). C,
plasma insulin level obtained from cort+/+ and cort2/2 animals fed
a LF- or HF-diet. Values represent mean 6 SEM of copy number
adjusted by normalization factor (NF) per 100 ng of cDNA obtained
from 4–7 animals per experimental group. (*: p,0,05).
doi:10.1371/journal.pone.0057834.g003
Figure 4. Expression profile of Insulin 1 and insulin 2 in
pancreatic islets of cort+/+ and cort2/2male mice fed a low fat
(LF) or high fat diet (HFD). Values represent mean 6 SEM of copy
number adjusted by b-actin expression per 100 ng of cDNA obtained
from 2–3 animals per experimental group. (*: p,0,05).
doi:10.1371/journal.pone.0057834.g004
Figure 5. Evaluation of in vitro CORT action on glucose
induced-Insulin release in cultured pancreatic islets from
cort2/2 mice. Values represent mean 6 SEM obtained from 3
independent experiments. Different letters stand for statistical differ-
ences (p,0,05).
doi:10.1371/journal.pone.0057834.g005
CORT Effect on Pancreatic Endocrine Function
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system components under physiological or pathological conditions
[33,34]. In addition, and similarly to that described for pancreatic
ghrelin system profile, In1-ghrelin variant is also predominantly
expressed under extreme metabolic conditions (obesity). These
data again support a relevant role of this ghrelin variant at the
pancreatic level that could be, at least in part, responsible for the
described actions of ghrelin related peptides on beta-cell survival
[33,34].
In clear contrast to the up-regulation of ghrelin system under
HFD conditions in cort +/+ mice described above, we observed
a clear shut-down of ghrelin system components in the whole
pancreas and islet-enriched culture of obese CORT deficient
animals. These findings would support a novel pathophysiological
role of CORT in the pancreatic function in individuals under
metabolic stress (obesity). Conversely, at the endocrine pancreas,
In1-ghrelin expression increased in cort2/2 obese animals,
throughout a mechanism still unclear that would specifically favor
the splicing of ghrelin gene to generate In1-ghrelin variant. These
findings suggest that native ghrelin and In-1 ghrelin variant might
be differentially regulated in cultured pancreatic islets in a similar
manner to that reported in the pituitary, hypothalamus and
stomach [13,19,31].
Besides ghrelin expression, our data also reveal a significant
increase of both insulin 1 and 2 mRNA transcripts in extracts from
whole pancreas (only insulin 2 transcripts in islet samples) under
obesity conditions. These data are in agreement with the elevation
of plasma insulin levels in obese animals observed in this study and
also documented by others [17,33,35]. However, in the pancreas
of HFD-fed cort2/2 animals, insulin expression remains at
control (LFD-fed) levels, although significantly diminished in islet
samples, thus suggesting and supporting a role for endogenous
CORT in regulating endocrine pancreas function, particularly on
beta-cell function.
Conclusions
The present study provides empirical evidence for an increased
pancreatic ghrelin system expression under obesity conditions.
Moreover, our findings demonstrate that the lack of endogenous
CORT (cort2/2 mice) prevents the up-regulation of all
components of the pancreatic ghrelin system as well as insulin
secretion (mRNA expression and release) induced by obesity in
cort+/+ mice, thereby suggesting that endogenous CORT may be
a key regulator of pancreatic endocrine function under normal and
particularly under pathophysiological states (obesity).
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